We’re excited to share that Serimmune is now part of Infinity Bio, Inc., a global leader in innovative antibody reactome services.
This partnership marks an exciting new chapter—combining Serimmune’s powerful short epitope profiling and discovery platform with Infinity Bio’s advanced technologies using rationally designed peptides and full-length proteins. Together, we’re accelerating progress in immunology research and translational science.
You’ll still have access to the science, innovation, and support you’ve come to expect—now with even more capabilities and resources.
🔬 New opportunities. Same commitment to science.